52
|
de Kleijn DP, Moll FL, Hellings WE, Ozsarlak-Sozer G, de Bruin P, Doevendans PA, Vink A, Catanzariti LM, Schoneveld AH, Algra A, Daemen MJ, Biessen E, de Jager W, Zhang H, de Vries JP, Falk E, Lim SK, van der Spek PJ, Sze SK, Pasterkamp G. Local Atherosclerotic Plaques Are a Source of Prognostic Biomarkers for Adverse Cardiovascular Events. Arterioscler Thromb Vasc Biol 2010; 30:612-9. [DOI: 10.1161/atvbaha.109.194944] [Citation(s) in RCA: 93] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
Objective—
Atherosclerotic cardiovascular disease is a major burden to health care. Because atherosclerosis is considered a systemic disease, we hypothesized that one single atherosclerotic plaque contains ample molecular information that predicts future cardiovascular events in all vascular territories.
Methods and Results—
AtheroExpress is a biobank collecting atherosclerotic lesions during surgery, with a 3-year follow-up. The composite primary outcome encompasses all cardiovascular events and interventions, eg, cardiovascular death, myocardial infarction, stroke, and endovascular interventions. A proteomics search identified osteopontin as a potential plaque biomarker. Patients undergoing carotid surgery (n=574) served as the cohort in which plaque osteopontin levels were examined in relation to their outcome during follow-up and was validated in a cohort of patients undergoing femoral endarterectomy (n=151). Comparing the highest quartile of carotid plaque osteopontin levels with quartile 1 showed a hazard ratio for the primary outcome of 3.8 (95% confidence interval, 2.6–5.9). The outcome did not change after adjustment for plaque characteristics and traditional risk factors (hazard ratio, 3.5; 95% confidence interval, 2.0–5.9). The femoral validation cohort showed a hazard ratio of 3.8 (95% confidence interval 2.0 to 7.4) comparing osteopontin levels in quartile 4 with quartile 1.
Conclusion—
Plaque osteopontin levels in single lesions are predictive for cardiovascular events in other vascular territories. Local atherosclerotic plaques are a source of prognostic biomarkers with a high predictive value for secondary manifestations of atherosclerotic disease.
Collapse
Affiliation(s)
- Dominique P.V. de Kleijn
- From Experimental Cardiology (D.P.V.d.K., W.E.H., G.O.-S., L.M.C., A.H.S., G.P.), Cardiology, DH&L, UMC Utrecht, the Netherlands; Interuniversity Cardiology Institute of the Netherlands (D.P.V.d.K., A.H.S.), Utrecht, the Netherlands; Genome Institute of Singapore (D.P.V.d.K.), Singapore; Department of Vascular Surgery (F.L.M., W.E.H.), UMC Utrecht, the Netherlands; Department of Pharmacology (G.O.-S.), Faculty of Pharmacy, Ege University, Izmir, Turkey; Department of Pathology (P.d.B.), St
| | - Frans L. Moll
- From Experimental Cardiology (D.P.V.d.K., W.E.H., G.O.-S., L.M.C., A.H.S., G.P.), Cardiology, DH&L, UMC Utrecht, the Netherlands; Interuniversity Cardiology Institute of the Netherlands (D.P.V.d.K., A.H.S.), Utrecht, the Netherlands; Genome Institute of Singapore (D.P.V.d.K.), Singapore; Department of Vascular Surgery (F.L.M., W.E.H.), UMC Utrecht, the Netherlands; Department of Pharmacology (G.O.-S.), Faculty of Pharmacy, Ege University, Izmir, Turkey; Department of Pathology (P.d.B.), St
| | - Willem E. Hellings
- From Experimental Cardiology (D.P.V.d.K., W.E.H., G.O.-S., L.M.C., A.H.S., G.P.), Cardiology, DH&L, UMC Utrecht, the Netherlands; Interuniversity Cardiology Institute of the Netherlands (D.P.V.d.K., A.H.S.), Utrecht, the Netherlands; Genome Institute of Singapore (D.P.V.d.K.), Singapore; Department of Vascular Surgery (F.L.M., W.E.H.), UMC Utrecht, the Netherlands; Department of Pharmacology (G.O.-S.), Faculty of Pharmacy, Ege University, Izmir, Turkey; Department of Pathology (P.d.B.), St
| | - Gonen Ozsarlak-Sozer
- From Experimental Cardiology (D.P.V.d.K., W.E.H., G.O.-S., L.M.C., A.H.S., G.P.), Cardiology, DH&L, UMC Utrecht, the Netherlands; Interuniversity Cardiology Institute of the Netherlands (D.P.V.d.K., A.H.S.), Utrecht, the Netherlands; Genome Institute of Singapore (D.P.V.d.K.), Singapore; Department of Vascular Surgery (F.L.M., W.E.H.), UMC Utrecht, the Netherlands; Department of Pharmacology (G.O.-S.), Faculty of Pharmacy, Ege University, Izmir, Turkey; Department of Pathology (P.d.B.), St
| | - Peter de Bruin
- From Experimental Cardiology (D.P.V.d.K., W.E.H., G.O.-S., L.M.C., A.H.S., G.P.), Cardiology, DH&L, UMC Utrecht, the Netherlands; Interuniversity Cardiology Institute of the Netherlands (D.P.V.d.K., A.H.S.), Utrecht, the Netherlands; Genome Institute of Singapore (D.P.V.d.K.), Singapore; Department of Vascular Surgery (F.L.M., W.E.H.), UMC Utrecht, the Netherlands; Department of Pharmacology (G.O.-S.), Faculty of Pharmacy, Ege University, Izmir, Turkey; Department of Pathology (P.d.B.), St
| | - Pieter A. Doevendans
- From Experimental Cardiology (D.P.V.d.K., W.E.H., G.O.-S., L.M.C., A.H.S., G.P.), Cardiology, DH&L, UMC Utrecht, the Netherlands; Interuniversity Cardiology Institute of the Netherlands (D.P.V.d.K., A.H.S.), Utrecht, the Netherlands; Genome Institute of Singapore (D.P.V.d.K.), Singapore; Department of Vascular Surgery (F.L.M., W.E.H.), UMC Utrecht, the Netherlands; Department of Pharmacology (G.O.-S.), Faculty of Pharmacy, Ege University, Izmir, Turkey; Department of Pathology (P.d.B.), St
| | - Aryan Vink
- From Experimental Cardiology (D.P.V.d.K., W.E.H., G.O.-S., L.M.C., A.H.S., G.P.), Cardiology, DH&L, UMC Utrecht, the Netherlands; Interuniversity Cardiology Institute of the Netherlands (D.P.V.d.K., A.H.S.), Utrecht, the Netherlands; Genome Institute of Singapore (D.P.V.d.K.), Singapore; Department of Vascular Surgery (F.L.M., W.E.H.), UMC Utrecht, the Netherlands; Department of Pharmacology (G.O.-S.), Faculty of Pharmacy, Ege University, Izmir, Turkey; Department of Pathology (P.d.B.), St
| | - Louise M. Catanzariti
- From Experimental Cardiology (D.P.V.d.K., W.E.H., G.O.-S., L.M.C., A.H.S., G.P.), Cardiology, DH&L, UMC Utrecht, the Netherlands; Interuniversity Cardiology Institute of the Netherlands (D.P.V.d.K., A.H.S.), Utrecht, the Netherlands; Genome Institute of Singapore (D.P.V.d.K.), Singapore; Department of Vascular Surgery (F.L.M., W.E.H.), UMC Utrecht, the Netherlands; Department of Pharmacology (G.O.-S.), Faculty of Pharmacy, Ege University, Izmir, Turkey; Department of Pathology (P.d.B.), St
| | - Arjan H. Schoneveld
- From Experimental Cardiology (D.P.V.d.K., W.E.H., G.O.-S., L.M.C., A.H.S., G.P.), Cardiology, DH&L, UMC Utrecht, the Netherlands; Interuniversity Cardiology Institute of the Netherlands (D.P.V.d.K., A.H.S.), Utrecht, the Netherlands; Genome Institute of Singapore (D.P.V.d.K.), Singapore; Department of Vascular Surgery (F.L.M., W.E.H.), UMC Utrecht, the Netherlands; Department of Pharmacology (G.O.-S.), Faculty of Pharmacy, Ege University, Izmir, Turkey; Department of Pathology (P.d.B.), St
| | - Ale Algra
- From Experimental Cardiology (D.P.V.d.K., W.E.H., G.O.-S., L.M.C., A.H.S., G.P.), Cardiology, DH&L, UMC Utrecht, the Netherlands; Interuniversity Cardiology Institute of the Netherlands (D.P.V.d.K., A.H.S.), Utrecht, the Netherlands; Genome Institute of Singapore (D.P.V.d.K.), Singapore; Department of Vascular Surgery (F.L.M., W.E.H.), UMC Utrecht, the Netherlands; Department of Pharmacology (G.O.-S.), Faculty of Pharmacy, Ege University, Izmir, Turkey; Department of Pathology (P.d.B.), St
| | - Mat J. Daemen
- From Experimental Cardiology (D.P.V.d.K., W.E.H., G.O.-S., L.M.C., A.H.S., G.P.), Cardiology, DH&L, UMC Utrecht, the Netherlands; Interuniversity Cardiology Institute of the Netherlands (D.P.V.d.K., A.H.S.), Utrecht, the Netherlands; Genome Institute of Singapore (D.P.V.d.K.), Singapore; Department of Vascular Surgery (F.L.M., W.E.H.), UMC Utrecht, the Netherlands; Department of Pharmacology (G.O.-S.), Faculty of Pharmacy, Ege University, Izmir, Turkey; Department of Pathology (P.d.B.), St
| | - E.A. Biessen
- From Experimental Cardiology (D.P.V.d.K., W.E.H., G.O.-S., L.M.C., A.H.S., G.P.), Cardiology, DH&L, UMC Utrecht, the Netherlands; Interuniversity Cardiology Institute of the Netherlands (D.P.V.d.K., A.H.S.), Utrecht, the Netherlands; Genome Institute of Singapore (D.P.V.d.K.), Singapore; Department of Vascular Surgery (F.L.M., W.E.H.), UMC Utrecht, the Netherlands; Department of Pharmacology (G.O.-S.), Faculty of Pharmacy, Ege University, Izmir, Turkey; Department of Pathology (P.d.B.), St
| | - W. de Jager
- From Experimental Cardiology (D.P.V.d.K., W.E.H., G.O.-S., L.M.C., A.H.S., G.P.), Cardiology, DH&L, UMC Utrecht, the Netherlands; Interuniversity Cardiology Institute of the Netherlands (D.P.V.d.K., A.H.S.), Utrecht, the Netherlands; Genome Institute of Singapore (D.P.V.d.K.), Singapore; Department of Vascular Surgery (F.L.M., W.E.H.), UMC Utrecht, the Netherlands; Department of Pharmacology (G.O.-S.), Faculty of Pharmacy, Ege University, Izmir, Turkey; Department of Pathology (P.d.B.), St
| | - Huoming Zhang
- From Experimental Cardiology (D.P.V.d.K., W.E.H., G.O.-S., L.M.C., A.H.S., G.P.), Cardiology, DH&L, UMC Utrecht, the Netherlands; Interuniversity Cardiology Institute of the Netherlands (D.P.V.d.K., A.H.S.), Utrecht, the Netherlands; Genome Institute of Singapore (D.P.V.d.K.), Singapore; Department of Vascular Surgery (F.L.M., W.E.H.), UMC Utrecht, the Netherlands; Department of Pharmacology (G.O.-S.), Faculty of Pharmacy, Ege University, Izmir, Turkey; Department of Pathology (P.d.B.), St
| | - Jean-Paul de Vries
- From Experimental Cardiology (D.P.V.d.K., W.E.H., G.O.-S., L.M.C., A.H.S., G.P.), Cardiology, DH&L, UMC Utrecht, the Netherlands; Interuniversity Cardiology Institute of the Netherlands (D.P.V.d.K., A.H.S.), Utrecht, the Netherlands; Genome Institute of Singapore (D.P.V.d.K.), Singapore; Department of Vascular Surgery (F.L.M., W.E.H.), UMC Utrecht, the Netherlands; Department of Pharmacology (G.O.-S.), Faculty of Pharmacy, Ege University, Izmir, Turkey; Department of Pathology (P.d.B.), St
| | - Erling Falk
- From Experimental Cardiology (D.P.V.d.K., W.E.H., G.O.-S., L.M.C., A.H.S., G.P.), Cardiology, DH&L, UMC Utrecht, the Netherlands; Interuniversity Cardiology Institute of the Netherlands (D.P.V.d.K., A.H.S.), Utrecht, the Netherlands; Genome Institute of Singapore (D.P.V.d.K.), Singapore; Department of Vascular Surgery (F.L.M., W.E.H.), UMC Utrecht, the Netherlands; Department of Pharmacology (G.O.-S.), Faculty of Pharmacy, Ege University, Izmir, Turkey; Department of Pathology (P.d.B.), St
| | - Sai K. Lim
- From Experimental Cardiology (D.P.V.d.K., W.E.H., G.O.-S., L.M.C., A.H.S., G.P.), Cardiology, DH&L, UMC Utrecht, the Netherlands; Interuniversity Cardiology Institute of the Netherlands (D.P.V.d.K., A.H.S.), Utrecht, the Netherlands; Genome Institute of Singapore (D.P.V.d.K.), Singapore; Department of Vascular Surgery (F.L.M., W.E.H.), UMC Utrecht, the Netherlands; Department of Pharmacology (G.O.-S.), Faculty of Pharmacy, Ege University, Izmir, Turkey; Department of Pathology (P.d.B.), St
| | - Peter J. van der Spek
- From Experimental Cardiology (D.P.V.d.K., W.E.H., G.O.-S., L.M.C., A.H.S., G.P.), Cardiology, DH&L, UMC Utrecht, the Netherlands; Interuniversity Cardiology Institute of the Netherlands (D.P.V.d.K., A.H.S.), Utrecht, the Netherlands; Genome Institute of Singapore (D.P.V.d.K.), Singapore; Department of Vascular Surgery (F.L.M., W.E.H.), UMC Utrecht, the Netherlands; Department of Pharmacology (G.O.-S.), Faculty of Pharmacy, Ege University, Izmir, Turkey; Department of Pathology (P.d.B.), St
| | - Siu Kwan Sze
- From Experimental Cardiology (D.P.V.d.K., W.E.H., G.O.-S., L.M.C., A.H.S., G.P.), Cardiology, DH&L, UMC Utrecht, the Netherlands; Interuniversity Cardiology Institute of the Netherlands (D.P.V.d.K., A.H.S.), Utrecht, the Netherlands; Genome Institute of Singapore (D.P.V.d.K.), Singapore; Department of Vascular Surgery (F.L.M., W.E.H.), UMC Utrecht, the Netherlands; Department of Pharmacology (G.O.-S.), Faculty of Pharmacy, Ege University, Izmir, Turkey; Department of Pathology (P.d.B.), St
| | - Gerard Pasterkamp
- From Experimental Cardiology (D.P.V.d.K., W.E.H., G.O.-S., L.M.C., A.H.S., G.P.), Cardiology, DH&L, UMC Utrecht, the Netherlands; Interuniversity Cardiology Institute of the Netherlands (D.P.V.d.K., A.H.S.), Utrecht, the Netherlands; Genome Institute of Singapore (D.P.V.d.K.), Singapore; Department of Vascular Surgery (F.L.M., W.E.H.), UMC Utrecht, the Netherlands; Department of Pharmacology (G.O.-S.), Faculty of Pharmacy, Ege University, Izmir, Turkey; Department of Pathology (P.d.B.), St
| |
Collapse
|